AIM IMMUNOTECH INC. Operating Loss Carryforwards
AIM IMMUNOTECH INC. (AIM) had Operating Loss Carryforwards of $14.16 million as of 2023-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Notes › Income Taxes
us-gaap:OperatingLossCarryforwards · last filed 2025-03-27
- 2023-12-31: Operating Loss Carryforwards $14.16M.
- 2015-12-31: Operating Loss Carryforwards $166.00M.
- 2014-12-31: Operating Loss Carryforwards $151.00M.
- 2013-12-31: Operating Loss Carryforwards $134.00M.
| Period end | Operating Loss Carryforwards |
|---|---|
| 2023-12-31 | $14.16M 10-K · filed 2025-03-27 |
| 2015-12-31 | $166.00M 10-Q · filed 2016-11-14 |
| 2014-12-31 | $151.00M 10-K · filed 2016-03-29 |
| 2013-12-31 | $134.00M 10-K · filed 2016-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |